Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TMO | +20.62% | +3.44% | +1.01% | +3.25% | +20.93% | +45.77% | +25.75% | +62.12% | +11.68% | +135.29% | +372.28% |
| K-GHEALTH | +9.73% | +3.09% | +5.13% | +8.16% | +6.96% | +16.82% | +15.29% | +28.77% | +1.38% | +49.36% | +96.30% |
| TGHSTARP | +8.91% | +2.71% | +4.67% | +6.85% | +6.98% | +16.76% | +15.83% | +24.83% | +0.25% | +37.03% | +72.05% |
| ES-HEALTHCARE | +10.42% | +2.20% | +4.89% | +6.25% | +3.71% | +14.71% | +19.72% | +44.52% | +19.76% | +68.68% | +115.63% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes TMO: money market or bond funds, or no holdings data yet
| K-GHEALTH | ES-HEALTHCARE | |
|---|---|---|
| Held by both | ||
 Eli Lilly and Co | 8.17% | 9.37% |
 Johnson & Johnson | 6.43% | 7.58% |
 ABBVIE | 7.45% | 4.81% |
 AstraZeneca | 4.19% | 3.62% |
 Unitedhealth Group | 3.37% | 4.16% |
 Thermo Fisher | 4.70% | 3.27% |
 Novartis | 4.59% | 2.66% |
 Merck & | 5.41% | 2.29% |
| Only in K-GHEALTH | ||
 Abbott Laboratories | 2.96% | N/A |
 Danaher | 2.96% | N/A |
| Only in ES-HEALTHCARE | ||
 Roche | N/A | 2.61% |
 argenx | N/A | 2.39% |
30 Dec 2025 → 30 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| TMO | +20.62% | 31.24% | 0.66 |
| K-GHEALTH | +9.73% | 15.51% | 0.63 |
| ES-HEALTHCARE | +10.42% | 16.63% | 0.63 |
| TGHSTARP | +8.91% | 15.03% | 0.59 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | TMO | K-GHEALTH | TGHSTARP | ES-HEALTHCARE |
|---|---|---|---|---|
Fund details | ||||
| Fund size | N/A | 3,113 million | 156 million | 863 million |
| Inception date | N/A | 26 Nov 2014 | 20 May 2015 | 6 Jul 2015 |
| Master fund | N/A | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | กองทุนที่ลงทุนหลายกอง (BlackRock Global Funds - World Healthscience) | กองทุน Janus Henderson Global Life Sciences Fund |
| Dividend policy | N/A | Pays | Does not pay | Does not pay |
Risk and currency hedging | ||||
| Risk level | N/A | 6 | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 93.16% | 91.65% | 94.05% |
Minimum purchase and redemption | ||||
| First purchase | N/A | 500 THB | 1,000 THB | 1 THB |
| Subsequent purchase | N/A | 500 THB | 1,000 THB | 1 THB |
| Redemption (amount) | N/A | 500 THB | No minimum | 1 THB |
| Redemption (units) | N/A | No minimum | No minimum | 1 units |
| Balance (amount) | N/A | 50 THB | No minimum | No minimum |
| Balance (units) | N/A | No minimum | 100 units | No minimum |
Order cut-off and redemption payment | ||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 14:30 | 15:30 | 15:30 |
| Redemption paid | N/A | T+4 | T+5 | T+4 |
